Nonionic magnetic resonance imaging contrast agents. Clinical trial experience of safety, tolerance, and efficacy of gadodiamide injection.
Van Wagoner
M
M
Salutar, Inc., Sunnyvale, California.
O'Toole
M
M
Quay
S C
SC
D000328:Adult; D003287:Contrast Media / Q000009:adverse effects / Q000493:pharmacokinetics; D004341:Drug Evaluation; D004361:Drug Tolerance; D005682:Gadolinium; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging; D009942:Organometallic Compounds / Q000009:adverse effects / Q000493:pharmacokinetics; D004369:Pentetic Acid / Q000009:adverse effects / Q000493:pharmacokinetics; D012449:Safety
D003287:Contrast Media; D009942:Organometallic Compounds; D004369:Pentetic Acid; C064925:gadodiamide; D005682:Gadolinium; D019786:Gadolinium DTPA